All Stories

  1. A new in vivo model to study the interactions between intracellular bacteria with their host
  2. Synthesis andantibacterial profiling of new derivatives of an immunomodulatory drug
  3. Clinical reasoning in pharmacy: What do eye movements and verbal protocols tell us about the processing of a case task?
  4. Unleashing the Potential of Medicinal Plants in Benin: Assessing the Status of Research and the Need for Enhanced Practices
  5. Repurposing the Sphingosine-1-Phosphate Receptor Modulator Etrasimod as an Antibacterial Agent Against Gram-Positive Bacteria
  6. Alterations in Bacterial Metabolism Contribute to the Lifespan Extension Exerted by Guarana in Caenorhabditis elegans
  7. A proteomics study on how Chlamydia pneumoniae affects macrophages
  8. The influence of dibenzocyclooctadiene lignans on macrophage glutathione and lipid metabolism associated with Chlamydia pneumoniae-induced foam cell formation
  9. University students' study progress
  10. Correction: Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
  11. a model to study C. pneumoniae infection
  12. Growth Mode and Physiological State of Cells Prior to Biofilm Formation Affect Immune Evasion and Persistence of Staphylococcus aureus
  13. Assaying Chlamydia pneumoniae Persistence in Monocyte-Derived Macrophages Identifies Dibenzocyclooctadiene Lignans as Phenotypic Switchers
  14. Assaying Chlamydia pneumoniae persistence in monocyte-derived macrophages identifies schisandrin lignans as phenotypic switchers
  15. Impact of dibenzocyclooctadiene lignans from Schisandra chinensis on the redox status and activation of human innate immune system cells
  16. Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy
  17. Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
  18. Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors
  19. Amphipathic β2,2-Amino Acid Derivatives Suppress Infectivity and Disrupt the Intracellular Replication Cycle of Chlamydia pneumoniae
  20. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses
  21. Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis
  22. Inhibitory Activity of the Isoflavone Biochanin A on Intracellular Bacteria of Genus Chlamydia and Initial Development of a Buccal Formulation
  23. How to Translate a Bioassay Into a Screening Assay for Natural Products: General Considerations and Implementation of Antimicrobial Screens
  24. Recent advances in technologies for developing drugs againstChlamydia pneumoniae
  25. Tailored beads made of dissolved cellulose—Investigation of their drug release properties
  26. Commercial peppermint (Mentha×piperita L.) teas: Antichlamydial effect and polyphenolic composition
  27. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques
  28. Aggregating Behavior of Phenolic Compounds — A Source of False Bioassay Results?
  29. Ent-kauren-19-oic acid derivatives from the stem bark of Croton pseudopulchellus Pax
  30. Conformation study of 2-arylbenzimidazoles as inhibitors of Chlamydia pneumoniae growth
  31. Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
  32. Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro
  33. Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae
  34. The Binding of Synthetic Retinoids to Lipocalin β-Lactoglobulins
  35. Betulin-Derived Compounds as Inhibitors of Alphavirus Replication
  36. A luciferase-based screening method for inhibitors of alphavirus replication applied to nucleoside analogues
  37. Comparison of transgenic Gerbera hybrida lines and traditional varieties shows no differences in cytotoxicity or metabolic fingerprints
  38. Predictive value of cellular methods in toxicological evaluation of lead candidates: an insight to hepatotoxicity
  39. Assessing the data quality in predictive toxicology using a panel of cell lines and cytotoxicity assays